Synairgen shares rise over 450% as COVID-19 drug has huge potential
The FINANCIAL -- Synairgen plc, the respiratory drug discovery and development company which originated from research at the University of Southampton, ...
ADVERTISEMENT
Tag: Southampton
ADVERTISEMENT
Popular Last 24h
-
Turkey’s EU Ambitions Face Hurdles as Black Sea Power Dynamics Shift
-
Optimist Fund Exits Following Xponential Fitness’ Founder-CEO Resignation
-
USAID’s Legacy: A Look at U.S. Spending and Impact in Georgia
-
Georgia’s Tourism Industry Poised for Growth
-
New FTC Data Show a Big Jump in Reported Losses to Fraud to $12.5 Billion in 2024
-
Ampersand wins £22m five-year contract at London Zoo
-
Can You Sue a Doctor for Sexual Abuse, and What Legal Steps Should You Take?
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
